Results 21 to 30 of about 136,305 (116)

Pharmaceutical pricing and reimbursement information (PPRI): evolution and impact of a policy network over two decades. [PDF]

J Pharm Policy Pract
Vogler S, Windisch F, Knoll V, Kieslich K.   +3 more
europepmc   +1 more source

Reimbursement Potential of Collaborative Care Model (CoCM) Billing Codes for Opioid Use Disorder Co-Occurring with Mental Disorders: Descriptive Estimates from a Pragmatic Trial. [PDF]

Adm Policy Ment Health
Dopp AR, Weir RL, Hindmarch GM, Pak L, Mendon-Plasek S, Schoenbaum M, Christensen J, Carrejo V, Bonham C, Komaromy M, Watkins KE.   +10 more
europepmc   +1 more source

Geographic Variability in Medicare Hospital Reimbursement for Primary Total Hip and Knee Arthroplasty Episodes of Care From 2013 to 2023. [PDF]

Arthroplast Today
Thompson AB, Paul BR, Haglin JM, Van Schuyver PR, Iturregui JM, Deckey DG, Bingham JS.   +6 more
europepmc   +1 more source

Unveiling trends: insights into medicines reimbursement recommendations and health technology management in Ireland (2018-2023). [PDF]

Int J Technol Assess Health Care
Aluga D, Gorry C, Barry M, Byrne P, Gillespie P, Smith SM.   +5 more
europepmc   +1 more source

Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study. [PDF]

Orphanet J Rare Dis
Antoni G, Kumps C, Berger J, Barman-Aksözen J, Tran C.   +4 more
europepmc   +1 more source

Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. [PDF]

ESMO Open
Blaye C, Bidard FC, Hue L, Howarth K, Pierga JY, Dalenc F, Jacot W, Djerroudi L, Potonnier W, Dumas V, Lalet C, Maréchal M, Pulido M, Brunet M, Salabert L, Venat L, Maran-Gonzalez A, Saal LH, Franchet C, Birkeälv S, MacGrogan G, Bonnefoi H.   +21 more
europepmc   +1 more source

"ID-ing" the value: how are orthopaedic infectious disease physicians compensated for their time? A national survey. [PDF]

J Bone Jt Infect
O'Neil JC, Lehman B, Seyler T, Piuzzi N, Ryan S, Seidelman J, Reznicek J, Sekar P.   +7 more
europepmc   +1 more source

Economic evidence on provider-level implications of direct posterior amalgam alternatives following the EU phase-out: a scoping review. [PDF]

BMJ Open
Oesterreicher J, Herz MM.
europepmc   +1 more source

Revisiting the Eight Basic Payment Methods in Health Care: A Contemporary Framework for Value-Based Policy and Practice in the United States. [PDF]

J Healthc Leadersh
Beauvais B, Ramamonjiarivelo Z, Mileski M, Shapley R, Pradhan R, Priore R.   +5 more
europepmc   +1 more source

Do conditional marketing authorisations actually accelerate patient access? Time-to-access of conditional vs. standard marketing authorisations in Italy, Spain, and Germany. [PDF]

J Pharm Policy Pract
Ardito V, Falk L, Gasol Boncompte M, Pontes C, Robinson J, Schreyögg J, Ciani O.   +6 more
europepmc   +1 more source